Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy

[1] Sung H(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA: A Cancer J Clin 71 209-249

[2] Ferlay J(2019)Cervical cancer Lancet (Lond, Engl) 393 169-182

[3] Siegel RL(1999)Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N Engl J Med 340 1137-1143

[4] Cohen PA(1999)Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 1144-1153

[5] Jhingran A(1999)Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1154-1161

[6] Oaknin A(1999)Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study J Clin Oncol 17 1339-1348

[7] Morris M(2000)Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 1606-1613

[8] Eifel PJ(2020)Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: a systematic review and meta-analysis Cancer Treat Rev 83 101945-776

[9] Lu J(2018)Survival nomograms after curative neoadjuvant chemotherapy and radical surgery for stage IB2-IIIB cervical cancer Cancer Res Treat 50 768-43

[10] Rose PG(2018)Immune check-point in cervical cancer Critical Rev Oncol Hematol 129 40-717

[1] Sung H(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA: A Cancer J Clin 71 209-249

[2] Ferlay J(2019)Cervical cancer Lancet (Lond, Engl) 393 169-182

[3] Siegel RL(1999)Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N Engl J Med 340 1137-1143

[4] Cohen PA(1999)Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 1144-1153

[5] Jhingran A(1999)Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1154-1161

[6] Oaknin A(1999)Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study J Clin Oncol 17 1339-1348

[7] Morris M(2000)Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 1606-1613

[8] Eifel PJ(2020)Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: a systematic review and meta-analysis Cancer Treat Rev 83 101945-776

[9] Lu J(2018)Survival nomograms after curative neoadjuvant chemotherapy and radical surgery for stage IB2-IIIB cervical cancer Cancer Res Treat 50 768-43

[10] Rose PG(2018)Immune check-point in cervical cancer Critical Rev Oncol Hematol 129 40-717